Evidence map›Paper›PMID 30669612›Full record

ReviewMolecules (Basel, Switzerland)2019

Roles of Phenolic Compounds in the Reduction of Risk Factors of Cardiovascular Diseases.

Mariane Lutz, Eduardo Fuentes, Felipe Ávila, Marcelo Alarcón, Iván Palomo

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mariane LutzThematic Task Force on Healthy Aging, CUECH Research Network, Santiago, Chile. mariane.lutz@uv.cl.
Eduardo FuentesThematic Task Force on Healthy Aging, CUECH Research Network, Santiago, Chile. edfuentes@utalca.cl.ORCID 0000-0003-0099-4108
Felipe ÁvilaThematic Task Force on Healthy Aging, CUECH Research Network, Santiago, Chile. favilac@utalca.cl.
Marcelo AlarcónThematic Task Force on Healthy Aging, CUECH Research Network, Santiago, Chile. malarcon@utalca.cl.
Iván PalomoThematic Task Force on Healthy Aging, CUECH Research Network, Santiago, Chile. ipalomo@utalca.cl.
University of Talca · CLViña del Mar University · CL

Funding

Consorcio de Universidades del Estado de Chile CUECH 000
6 · The paper itself

Abstract

The population is now living longer during the period classified as "elderly" (60 years and older), exhibiting multimorbidity associated to the lengthening of the average life span. The dietary intake of phenolic compounds (PC) may affect the physiology, disease development and progression during the aging process, reducing risk factors of age related diseases. The aim of this review is to briefly describe some of the possible effects of a series of PC on the reduction of risk factors of the onset of cardiovascular diseases, considering their potential mechanisms of action. The main actions described for PC are associated with reduced platelet activity, anti-inflammatory effects, and the protection from oxidation to reduce LDL and the generation of advanced glycation end products. Preclinical and clinical evidence of the physiological effects of various PC is presented, as well as the health claims approved by regulatory agencies.

Indexed as

AgingAnimalsAnti-Inflammatory AgentsAntioxidantsBiological AvailabilityCardiovascular DiseasesDietary SupplementsGastrointestinal MicrobiomeHumansInsurance BenefitsPhenolsPlatelet Aggregation InhibitorsRisk FactorsAnti-Inflammatory AgentsAntioxidantsPhenolsPlatelet Aggregation Inhibitorsage related diseasesagingatherothrombosiscardiovascular diseasehealth claimsoxidative stressphenolic compoundsplatelets

Identifiers

PMID30669612
PMCPMC6359321
OpenAlexW2909508818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.